Kolaviron ameliorates behavioural deficit and injury to striatal dopaminergic terminals via modulation of oxidative burden, DJ-1 depletion and CD45R+ cells infiltration in MPTP-model of Parkinson’s disease
Ebenezer O. Farombi, Ifeoluwa O. Awogbindin, Olatunde Owoeye, Victoria O. Abah, Edirin R. Izomoh, Ibukunoluwa O. Ezekiel
Topics & Concepts
MPTPNeuroprotectionNeuroinflammationNeurodegenerationPharmacologyOxidative stressParkinson's diseaseDopaminergicNeuroscienceMedicineDopamineImmunologyInternal medicinePsychologyInflammationDiseaseParkinson's Disease Mechanisms and TreatmentsNatural Compound Pharmacology StudiesRestless Legs Syndrome Research